SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Laura Di Magno, Sonia Coni, Lucia Di Marcotullio, Gianluca Canettieri, Digging a hole under Hedgehog: downstream inhibition as an emerging anticancer strategy, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2015, 1856, 1, 62

    CrossRef

  2. 2
    Chiara Raggi, Pietro Invernizzi, Jesper B. Andersen, Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: Molecular networks and biological concepts, Journal of Hepatology, 2015, 62, 1, 198

    CrossRef

  3. 3
    Koji Tanaka, Hiroshi Miyata, Keijiro Sugimura, Shuichi Fukuda, Takashi Kanemura, Kotaro Yamashita, Yasuhiro Miyazaki, Tsuyoshi Takahashi, Yukinori Kurokawa, Makoto Yamasaki, Hisashi Wada, Kiyokazu Nakajima, Shuji Takiguchi, Masaki Mori, Yuichiro Doki, miR-27 is associated with chemoresistance in esophageal cancer through transformation of normal fibroblasts to cancer-associated fibroblasts, Carcinogenesis, 2015, 36, 8, 894

    CrossRef

  4. You have free access to this content4
    Jesper B. Andersen, Molecular pathogenesis of intrahepatic cholangiocarcinoma, Journal of Hepato-Biliary-Pancreatic Sciences, 2015, 22, 2
  5. 5
    Benjamin Juntermanns, Svenja Sydor, Gernot M. Kaiser, Derar Jaradat, Joachim C. Mertens, Georgios C. Sotiropoulos, Sandra Swoboda, Jan P. Neuhaus, Wei Meng, Zoltan Mathé, Hideo A. Baba, Ali Canbay, Andreas Paul, Christian D. Fingas, Polo-like kinase 3 is associated with improved overall survival in cholangiocarcinoma, Liver International, 2015, 35, 8
  6. 6
    Fabio Marra, Alessandra Caligiuri, Stellate Cells in Health and Disease, 2015,

    CrossRef

  7. 7
    Jesper B Andersen, Snorri S Thorgeirsson, A perspective on molecular therapy in cholangiocarcinoma: present status and future directions, Hepatic Oncology, 2014, 1, 1, 143

    CrossRef

  8. 8
    Tobias Kiesslich, Christian Mayr, Julia Wachter, Doris Bach, Julia Fuereder, Andrej Wagner, Beate Alinger, Martin Pichler, Pietro Di Fazio, Matthias Ocker, Frieder Berr, Daniel Neureiter, Activated hedgehog pathway is a potential target for pharmacological intervention in biliary tract cancer, Molecular and Cellular Biochemistry, 2014, 396, 1-2, 257

    CrossRef

  9. 9
    Isaac S. Chan, Cynthia D. Guy, Mariana V. Machado, Abigail Wank, Vishnu Kadiyala, Gregory Michelotti, Steve Choi, Marzena Swiderska-Syn, Gamze Karaca, Thiago A. Pereira, Michele T. Yip-Schneider, C. Max Schmidt, Anna Mae Diehl, Alcohol Activates the Hedgehog Pathway and Induces Related Procarcinogenic Processes in the Alcohol-Preferring Rat Model of Hepatocarcinogenesis, Alcoholism: Clinical and Experimental Research, 2014, 38, 3
  10. 10
    Yoshihiko Aoki, Masaya Sugiyama, Kazumoto Murata, Sachiyo Yoshio, Masayuki Kurosaki, Satoru Hashimoto, Hiroshi Yatsuhashi, Hideyuki Nomura, Jong-Hon Kang, Tsutomu Takeda, Shigeko Naito, Tatsuji Kimura, Yoko Yamagiwa, Masaaki Korenaga, Masatoshi Imamura, Naohiko Masaki, Namiki Izumi, Masayoshi Kage, Masashi Mizokami, Tatsuya Kanto, Association of serum IFN-λ3 with inflammatory and fibrosis markers in patients with chronic hepatitis C virus infection, Journal of Gastroenterology, 2014,

    CrossRef

  11. 11
    Nataliya Razumilava, Gregory J Gores, Cholangiocarcinoma, The Lancet, 2014, 383, 9935, 2168

    CrossRef

  12. 12
    Alphonse E. Sirica, Gregory J. Gores, Desmoplastic stroma and cholangiocarcinoma: Clinical implications and therapeutic targeting, Hepatology, 2014, 59, 6
  13. 13
    Dorothee Riedlinger, Marcus Bahra, Sabine Boas-Knoop, Steffen Lippert, Maren Bradtmöller, Katrin Guse, Daniel Seehofer, Roberta Bova, Igor M Sauer, Peter Neuhaus, Arend Koch, Carsten Kamphues, Hedgehog pathway as a potential treatment target in human cholangiocarcinoma, Journal of Hepato-Biliary-Pancreatic Sciences, 2014, 21, 8
  14. 14
    Younjoo Kim, Myeong-ok Kim, Jin Sun Shin, Sun Hoo Park, Sang Bum Kim, Jin Kim, Su Cheol Park, Chul Ju Han, Ji Kon Ryu, Yong Bum Yoon, Yong-Tae Kim, Hedgehog Signaling Between Cancer Cells and Hepatic Stellate Cells in Promoting Cholangiocarcinoma, Annals of Surgical Oncology, 2014, 21, 8, 2684

    CrossRef

  15. 15
    Lalita A. Shevde, Rajeev S. Samant, Nonclassical hedgehog-gli signaling and its clinical implications, International Journal of Cancer, 2014, 135, 1
  16. 16
    Melanie Byrne Thomas, Systemic and Targeted Therapy for Biliary Tract Tumors and Primary Liver Tumors, Surgical Oncology Clinics of North America, 2014, 23, 2, 369

    CrossRef

  17. 17
    J.-N. Dauendorffer, S. Fraitag, A. Dupuy, Carcinome basocellulaire après « réjuvénation » par injection de plasma autologue riche en plaquettes, Annales de Dermatologie et de Vénéréologie, 2013, 140, 11, 723

    CrossRef

  18. 18
    Audrey Clapéron, Martine Mergey, Lynda Aoudjehane, Thanh Huong Nguyen Ho-Bouldoires, Dominique Wendum, Aurélie Prignon, Fatiha Merabtene, Delphine Firrincieli, Christèle Desbois-Mouthon, Olivier Scatton, Filomena Conti, Chantal Housset, Laura Fouassier, Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor, Hepatology, 2013, 58, 6
  19. 19
    Mona El Khatib, Anna Kalnytska, Vindhya Palagani, Uta Kossatz, Michael P. Manns, Nisar P. Malek, Ludwig Wilkens, Ruben R. Plentz, Inhibition of hedgehog signaling attenuates carcinogenesis in vitro and increases necrosis of cholangiocellular carcinoma, Hepatology, 2013, 57, 3
  20. 20
    D Sia, V Tovar, A Moeini, J M Llovet, Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies, Oncogene, 2013, 32, 41, 4861

    CrossRef

  21. 21
    Sara Lemoinne, Axelle Cadoret, Haquima El Mourabit, Dominique Thabut, Chantal Housset, Origins and functions of liver myofibroblasts, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013, 1832, 7, 948

    CrossRef

  22. 22
    Sumera Rizvi, Gregory J. Gores, Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma, Gastroenterology, 2013, 145, 6, 1215

    CrossRef

  23. 23
    Carmen Berasain, Matias A. Ávila, Platelet-derived growth factor D: A new player in the complex cross-talk between cholangiocarcinoma cells and cancer-associated fibroblasts, Hepatology, 2013, 58, 3
  24. 24
    Massimiliano Cadamuro, Giorgia Nardo, Stefano Indraccolo, Luigi Dall'Olmo, Luisa Sambado, Lidia Moserle, Irene Franceschet, Michele Colledan, Marco Massani, Tommaso Stecca, Nicolò Bassi, Stuart Morton, Carlo Spirli, Romina Fiorotto, Luca Fabris, Mario Strazzabosco, Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma, Hepatology, 2013, 58, 3
  25. 25
    Christian D. Fingas, Joachim C. Mertens, Nataliya Razumilava, Svenja Sydor, Steven F. Bronk, John D. Christensen, Sumera H. Rizvi, Ali Canbay, Jürgen W. Treckmann, Andreas Paul, Alphonse E. Sirica, Gregory J. Gores, Polo-like kinase 2 is a mediator of hedgehog survival signaling in cholangiocarcinoma, Hepatology, 2013, 58, 4
  26. 26
    Carola M Morell, Luca Fabris, Mario Strazzabosco, Vascular biology of the biliary epithelium, Journal of Gastroenterology and Hepatology, 2013, 28,
  27. 27
    Magali Castells, Benoît Thibault, Jean-Pierre Delord, Bettina Couderc, Implication of Tumor Microenvironment in Chemoresistance: Tumor-Associated Stromal Cells Protect Tumor Cells from Cell Death, International Journal of Molecular Sciences, 2012, 13, 12, 9545

    CrossRef

  28. 28
    Th. Hager, C. Sergi, J. Hager, Sacrococcygeal Teratoma – a single center study of 43 years (1968–2011) including follow-up data and histopathological reevaluation of specimens, European Surgery, 2012, 44, 4, 255

    CrossRef

  29. 29
    Christian D. Fingas, Joachim C. Mertens, Nataliya Razumilava, Steven F. Bronk, Alphonse E. Sirica, Gregory J. Gores, Targeting PDGFR-β in Cholangiocarcinoma, Liver International, 2012, 32, 3